We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.65%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.5M
AUM Growth
-$129M
Cap. Flow
+$5.75M
Cap. Flow %
7.23%
Top 10 Hldgs %
61.99%
Holding
120
New
40
Increased
18
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
SHIP icon
Seanergy Maritime Holdings
SHIP
+$3.88M
2
ATNM icon
Actinium Pharmaceuticals
ATNM
+$2.79M
3
SLS icon
SELLAS Life Sciences
SLS
+$2.79M
4
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.78M
5
RDGT
Ridgetech Inc
RDGT
+$2.6M

Top Sells

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.41M
2
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$2.28M
3
LOOP icon
Loop Industries
LOOP
+$1.97M
4
BIIB icon
Biogen
BIIB
+$1.62M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 36.62%
2 Industrials 1.78%
3 Technology 1.66%
4 Consumer Discretionary 1.42%
5 Real Estate 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OGEN icon
26
Oragenics
OGEN
$2.24M
$617K 0.78%
700
+416
+146% +$382K
VXRT
27
DELISTED
Vaxart
VXRT
$617K 0.78%
920,647
+723,646
+367% +$606K
CANF
28
Can-Fite BioPharma American Depositary Shares
CANF
$6.77M
$610K 0.77%
+1,059
New +$1.16M
AMRN
29
Amarin Corp
AMRN
$293M
$609K 0.77%
+1,572
New +$576K
AUPH icon
30
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
$596K 0.75%
+906
New +$5.77K
BCLI
31
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$532K 0.67%
+133
New +$7.74K
TOVX icon
32
Theriva Biologics
TOVX
$9.8M
$497K 0.62%
3,615
+875
+32% +$126K
STOK icon
33
Stoke Therapeutics
STOK
$1.83B
$473K 0.59%
+16,202
New +$435K
SLS icon
34
SELLAS Life Sciences
SLS
$1.98B
$442K 0.56%
+78,520
New +$2.79M
MBOT icon
35
Microbot Medical
MBOT
$113M
$429K 0.54%
83,333
– –
AMRN
36
CALL
Amarin Corp
AMRN
$293M
$401K 0.5%
10
-64
-86% -$23.4K
EMAN
37
DELISTED
eMagin Corporation
EMAN
$392K 0.49%
+861,903
New +$480K
OEF icon
38
CALL
iShares S&P 100 ETF
OEF
$19.8B
$390K 0.49%
496
+136
+38% +$17.4K
SCON
39
DELISTED
Superconductor Technologies Inc.
SCON
$384K 0.48%
46,790
+20,643
+79% +$254K
XTIA icon
40
XTI Aerospace
XTIA
$57.3M
– –
0
– –
CYTR
41
DELISTED
CytRx Corp
CYTR
$366K 0.46%
1,060,999
+86,054
+9% +$48.4K
CYTO
42
DELISTED
Altamira Therapeutics Ltd
CYTO
$342K 0.43%
+309
New +$537K
LFWD icon
43
ReWalk Robotics
LFWD
$19.6M
$341K 0.43%
932
+496
+114% +$165K
NURO
44
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$332K 0.42%
10,119
+6,275
+163% +$367K
SPY icon
45
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$315K 0.4%
920
-856
-48% -$246K
NTBL
46
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$311K 0.39%
6,834
-2,523
-27% -$115K
ABIL
47
DELISTED
Ability Inc
ABIL
$277K 0.35%
301,137
-92,835
-24% -$124K
OEF icon
48
PUT
iShares S&P 100 ETF
OEF
$19.8B
$275K 0.35%
2,556
+340
+15% +$43.4K
BLIN icon
49
Bridgeline Digital
BLIN
$14.9M
$270K 0.34%
110,400
+108,400
+5,420% +$625K
AIM
50
AIM ImmunoTech
AIM
$6.54M
$267K 0.34%
+609
New +$368K
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sabby Management held 120 positions worth $79.5M, down 62% from $208M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management deployed $5.75M of net new capital in Q2 2019, opening 40 new positions and adding to 18 existing holdings. Its largest new stake was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Odonate Therapeutics, Inc. Common Stock, an estimated $2.41M trimmed.

  • Sabby Management's largest Q2 2019 buy was Seanergy Maritime Holdings: 10,437 shares worth $1.03M.
  • Sabby Management added most to Bridgeline Digital in Q2 2019, an estimated $625K increase.
  • Sabby Management's biggest Q2 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $2.41M.
  • Sabby Management fully exited Loop Industries in Q2 2019, selling an estimated $1.97M.
  • Sabby Management's ten largest holdings make up 62% of its $79.5M portfolio in Q2 2019.
  • Sabby Management opened 40 new positions and closed 32 in Q2 2019.
  • Sabby Management's portfolio value fell 62% quarter-over-quarter to $79.5M.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.